
David Kavanagh
executiveMale0.0Global Dominance: 0.00%
David Kavanagh is the Acting General Manager of IROS, and he emphasizes the significance of translating a decade of genomic investment in the UAE into practical clinical research, particularly through the pioneering Alzheimer's prevention trial that utilizes insights from the UAE Genome Program.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
David Kavanagh, the Acting General Manager of IROS, stated that the trial represents a clinical translation of a decade of investment in genomics in the UAE.
برنامج الجينوم الإماراتي يقود أول تجربة سريرية للوقاية من الزهايمر في الدولةAl Ittihad·
United Arab Emirates· 2026-06-29


